Overview

Value creation & strategy consulting firm focusing on Rare Diseases & Oncology. Corporate strategy, business development & new product entry analysis & recommendations. Identification, evaluation and in-licensing of promising assets. Development of value proposition and supporting early growth. Development and evaluation of goals, strategies, tactics and action plans to support successful global commercialization and corporate growth. Strategic recommendations for market access, pricing & reimbursement and commercialization of oncology & orphan drugs.